penfluridol has been researched along with procyclidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Annable, L; Chouinard, G; Cooper, S | 1 |
| Adlersberg, S; Averbuch, E; Gonen, N; Mester, R; Spivak, B; Weizman, A | 1 |
3 other study(ies) available for penfluridol and procyclidine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Antiparkinsonian drug administration and plasma levels of penfluridol, a new long-acting neuroleptic.
Topics: Adult; Antiparkinson Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Penfluridol; Piperidines; Procyclidine; Schizophrenia; Time Factors | 1977 |
Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Male; Muscarinic Antagonists; Neuroleptic Malignant Syndrome; Penfluridol; Procyclidine; Schizophrenia; Substance Withdrawal Syndrome; Trihexyphenidyl | 1996 |